Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BioArctic | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 15.58B | 17.3x | 0.02 | SEK 175.90 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cereno Scientific | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 3.12B | -29.4x | 0.46 | SEK 11.06 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioInvent International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.41B | -5.1x | 0.13 | SEK 36.40 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intellego Technologies AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.24B | 18.3x | 0.38 | SEK 73.30 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Devyser Diagnostics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.94B | -24.9x | 0.56 | SEK 116.20 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36% Upside | Upgrade to Pro+ | |
Vicore Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.81B | -4.1x | -0.65 | SEK 7.69 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hansa Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.64B | -2.6x | -0.06 | SEK 24.18 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Egetis Therapeutics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.54B | -4.2x | -0.21 | SEK 4.32 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XSpray Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.41B | -5.1x | 3.45 | SEK 37.85 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.6% Upside | Upgrade to Pro+ | |
Saniona AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.36B | 5.2x | 0.03 | SEK 10.04 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.6% Upside | Upgrade to Pro+ | |
Diamyd Medical | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.29B | -5.5x | 0.36 | SEK 9.49 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanoform Finland Plc | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 955.67M | -3.8x | -0.29 | SEK 10.82 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynAct Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 805.71M | -8x | -0.15 | SEK 17.68 | 7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.7% Upside | Upgrade to Pro+ | |
Hamlet Pharma AB | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 656.55M | -17.3x | -1.06 | SEK 4.17 | 12.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ascelia Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 503.55M | -3.8x | -0.11 | SEK 4.51 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.8% Upside | Upgrade to Pro+ | |
Xbrane Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 383.05M | -2.5x | -0.02 | SEK 0.25 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mendus AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 369.80M | -2.9x | -0.11 | SEK 7.20 | -5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guard Therapeutics | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 343.86M | -1.7x | 0.22 | SEK 17.05 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncopeptides | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 334.12M | -1x | -0.03 | SEK 1.49 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35% Upside | Upgrade to Pro+ | |
Promimic AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 331.56M | -25.1x | 0.6 | SEK 18 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intervacc | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 325.48M | -1.3x | -0.09 | SEK 0.97 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cantargia AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 315.74M | -1.5x | -0.04 | SEK 1.26 | 6.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Xintela | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 280.97M | -7x | -0.18 | SEK 0.42 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Active Biotech | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 249.72M | -3.4x | -0.1 | SEK 0.20 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AlzeCure Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 231.33M | -6.3x | -0.22 | SEK 2.67 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Initiator Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 226.32M | -13.6x | -0.34 | SEK 4.03 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kancera AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 214.50M | -4.8x | -0.1 | SEK 1.77 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.1% Downside | Upgrade to Pro+ | |
Alligator Bioscience | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 194.97M | -0.1x | -0.01 | SEK 5.63 | 12.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Annexin Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 182.83M | -2.9x | -0.08 | SEK 26.70 | -6.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medivir B | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 182.83M | -1.8x | -0.06 | SEK 1.64 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glycorex Transplantation | NGM | Healthcare | Biotechnology & Medical Research | SEK 177.42M | -18.8x | -0.29 | SEK 2.25 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alzinova | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 169M | -6x | -0.26 | SEK 1.62 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lumito AB | NGM | Healthcare | Biotechnology & Medical Research | SEK 167.78M | -2.1x | 0.07 | SEK 0.63 | -8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SenzaGen | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 158.73M | -8.1x | -0.39 | SEK 5.38 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curasight AS | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 141.55M | -2.8x | 0.38 | SEK 3.14 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Spago Nanomedical AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 139.28M | -4x | -0.05 | SEK 0.40 | 40.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11.2% Downside | Upgrade to Pro+ | |
Biosergen AS | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 132.91M | -8.2x | -0.09 | SEK 0.53 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dextech Medical | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 129.40M | -28.8x | SEK 7.20 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Bio-Works | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 126.37M | -2.9x | -0.06 | SEK 1.61 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IDL Diagnostics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 117.48M | -2.6x | -0.13 | SEK 0.51 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NextCell Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 115.63M | -1.7x | -0.07 | SEK 1.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abera Bioscience | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 113.61M | -153.7x | -1.6 | SEK 7 | -5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.3% Upside | Upgrade to Pro+ | |
2cureX | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 89.37M | -2.4x | -0.22 | SEK 3.55 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coegin Pharma AB | NGM | Healthcare | Biotechnology & Medical Research | SEK 80.85M | -3.4x | -0.06 | SEK 3.25 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biovica International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 71.97M | -0.8x | -0.02 | SEK 0.74 | -8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acousort | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 70.90M | -3.3x | -0.23 | SEK 3.35 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Klaria Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 60.22M | -1.5x | -0.05 | SEK 0.42 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sprint Bioscience AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 52.55M | -1.7x | 0.01 | SEK 0.50 | 5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carbiotix AB | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 50.37M | -3x | -0.06 | SEK 10.50 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Combigene | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 48.91M | -1.1x | 0.04 | SEK 2.47 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |